Brief: Zivo Bioscience Receives Nasdaq Notice Of Delisting Or Failure
26/05/2023 21:37
May 26 (Reuters) - Zivo Bioscience Inc ZIVO.O :
* ZIVO BIOSCIENCE INC - ON MAY 23, CO RECEIVED NOTICE OF
DELISTING OR FAILURE TO SATISFY CONTINUED LISTING RULE OR
STANDARD, TRANSFER OF LISTING NASDAQ
Further company coverage: ZIVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zivo Bioscience
See all newsBrief: Zivo Bioscience Plans New Study With University Of Delaware To Combat Avian Influenza In Poultry
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens